Literature DB >> 33686250

Venetoclax does not impair activated T-cell proliferation.

Lama Siblany1,2, Béatrice Gaugler1,2, Nicolas Stocker1,2, Laure Ricard1,2, Yishan Ye1, Mohamad Mohty1,2, Florent Malard3,4.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 33686250     DOI： 10.1038/s41409-021-01245-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia.

Authors:  Abhishek Maiti; Marina Y Konopleva
Journal:  Cancer J       Date:  2022 Jan-Feb 01       Impact factor: 3.360

Review 2.  Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering.

Authors:  Yishan Ye; Luxin Yang; Xiaolin Yuan; He Huang; Yi Luo
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.